Market Dynamics
NGS is used in a variety of applications, including biomarker exploration, oncology trials, personalized medicine, agricultural and animal testing, and so on. NGS has simplified nucleotide analysis and has effectively replaced traditional genomics tools, especially microarrays. As a result, the aforementioned factors contribute to the growth of the global next-generation sequencing market share. The market is expected to expand due to factors such as technological advances, increased NGS applications, and an increase in genome mapping programs. Furthermore, market growth is expected to be fueled by the demand for personalized medicine and rapid advancements in companion diagnostics production. Because of technical advances in NGS, an increase in NGS applications, and an increase in alliances and collaborations, the global next generation sequencing market is growing. Furthermore, the increase in genome mapping programs propels the global next generation sequencing market forward. ALSO READ @ http://www.marketwatch.com/story/next-generation-sequencing-market-segmented-by-product-covid-19-impact-top-manufacturers-geography-trends-forecasts-to-2025-2021-01-17 Market Segmentation The Global Next-Generation Sequencing Market has been segmented into Technology, Workflow, Application, End User, and Region. Based on technology, the global next-generation sequencing market has been divided into targeted sequencing & resequencing, whole-genome sequencing, and whole-exome sequencing. Based on workflow, the global next-generation sequencing market has been divided into pre-sequencing, sequencing, and data analysis. The global next-generation sequencing market, by applications, has been segmented into oncology, clinical investigation, reproductive health, human leukocyte antigen typing or immune system monitoring, metagenomics, epidemiology, and drug development, agrigenomics & forensics, consumer genomics, and others. The global next-generation sequencing market, by end-user, has been segmented into hospitals & clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Competitive Landscape Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), Genome Life Sciences (India), GenScript (US), Illumina, Inc. (US), Thermo Fisher Scientific (US), Qiagen (Germany), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences of California, Inc. (US), Xcelris Genomics (India), Macrogen, Inc. (South Korea), BGI (US), Charles River (US), and Oxford Nanopore Technologies (UK) are some of the key players operating in the global next generation sequencing market. Key Market OpportunitiesFavorable funding scenario and immense support for scientific research would augment the next-generation sequencing READ MORE @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354 Key Market Drivers Rising technological advancements, increasing applications of NGS, and growth in genome mapping programs. Increasing demand for personalized medicine and high growth in the development of companion diagnostics RELATED REPORTS Dental Carpule Market Research Report - Global Forecast to 2027 Global Medically prescribed apps Market Report - Forecast to 2027 Global Leuprolide Acetate Market Research Report - Forecast to 2027 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Market Highlights
Factors such as the increasing prevalence of chronic diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic and treatment technologies boost the market. However, low awareness and lack of healthcare services in the middle and low-income countries are estimated to restrain the market growth during the projected period. also read @ https://www.marketwatch.com/press-release/biobanking-market-growth-status-strategies-key-factors-comprehensive-analysis-competitive-landscape-and-forecast-2021-01-17 Biobanking Market Segmentation The global biobanking market is segmented by products and services, sample type, storage type, application, and end-user. On the basis of products and services, the biobanking market is segmented into equipment, services, consumables, and software. Equipment is further sub-segmented into sample transport equipment, sample processing equipment, storage equipment, sample analysis equipment, and others. Consumables are further sub-segmented into processing consumables, storage consumables, analysis consumables, collection consumables, and others. Services are sub-segmented into processing services, storage services, transport services, and supply services. By sample type, the biobanking market is segmented into biological fluids, blood products, cell lines, human tissues, nucleic acids, and others. Based on storage type the biobanking market is segmented into manual storage and automated storage. Applications of the market include life science research, regenerative medicine, and clinical research. By end-user, the Biobanking Market Growth is segmented into research centers, hospitals, diagnostic laboratory, and others. Biobanking Market Regional Analysis Based on region the biobanking market is segmented into Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas region is segmented into North America and South America. The Americas is the largest biobanking market due to heavy investments in research of theranostics and a large patient pool suffering from chronic diseases. Presence of large number of biobanks in hospitals in the U.S. can encourage growth in North America. On the other hand, South America can grow at a rapid pace due to increasing demand for advanced treatments for chronic diseases and technologically advanced diagnostic devices. Europe can also exhibit a stellar growth rate during the forecast period due to emphasis on research and development activities in diagnosis and treatment of diseases. Collaboration between biobanks and pharmaceutical companies for encouraging research can drive the global biobanking market growth. On the other hand, APAC can be lucrative for the global biobanking market due to inclination towards drug discovery and scientific research. Biobanking Market Competition Outlook Tecan Trading AG, Qiagen N.V., Brooks Automation, Inc., VWR Corporation, Becton, Dickinson and Company, Promega Corporation, Hamilton Company, Panasonic Healthcare Holdings Co., Ltd., Greiner Holding AG, Thermo Fisher Scientific Inc., Chart Industries, Inc., Merck KGaA, and others are notable players of the global biobanking market. Browse More Details at: https://www.marketresearchfuture.com/reports/biobanking-market-5967 More Healthcare Industry Related Reports Orthopedic Braces Market Research Report - Global Forecast till 2027 Clinical Trials Market Research Report - Forecast to 2027 Digital Diabetes Management Market Research Report – Global Forecast till 2027 Biobanking Industry News The Manchester Cancer Research Center biobank collects ovarian cysts samples from women afflicted with the disease. This sample can be used in the testing of new drugs and its efficacy for its future commercialization. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Thoracic Outlet Syndrome Treatment Market Application, Key Players, Share, Trends, Revenue 20275/28/2021 Market Highlights
There are two major types of pancreatic cancer, endocrine pancreas cancer and exocrine pancreas cancer. The patient with pancreatic cancer are more susceptible to jaundice, weight loss, diabetes, or pain in the stomach area or back. The mortality is increasing with the increasing prevalence of this type of cancer many countries. Thus, it requires regular surveillance. Increasing prevalence of pancreatic cancer, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology are expected to fuel the market during the forecast period. However, high cost of the treatment may slow the market growth during the period 2017-2023. ALSO READ @ https://www.medgadget.com/2019/10/pancreatic-cancer-market-trends-size-share-treatment-drug-pharmaceuticals-and-healthcare-analysis-therapy-and-geography-analysis-growth-shares-and-insights-research-up-to-2023industry-growth.html Key Players for Global Pancreatic Cancer Market Some of key the players in the market are Pharmacyte Biotech Inc. (U.S.), OncoGenex Pharmaceuticals Inc. (U.S.), Oncolytics Biotech (Canada), Diffusion Pharmaceuticals (U.S.), Polaris Pharmaceuticals, Inc. (U.S.), Sun BioPharma, Inc. (U.S.), Midatech Pharma PLC (U.K.), Eli Lilly and Company (U.S.), Celgene Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Amgen, Inc. (U.S.), Novartis International AG (U.S.), Clovis Oncology (U.S.), and others. Segments for Global Pancreatic Cancer Market The Americas dominate the global Pancreatic Cancer Treatment Market Share owing to well-developed technology, increasing patient with cancer, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region. Europe holds the second position in the global pancreatic cancer market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain. Asia Pacific is the fastest growing pancreatic cancer market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. On the other hand, in the Middle East and Africa, pancreatic cancer has become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment. Segments for Global Pancreatic Cancer Market The Global Pancreatic Cancer Market is segmented on the basis of types, treatment, and end user. On the basis of the type, it is segmented into endocrine pancreas cancer, exocrine pancreas cancer, and others. On the basis of the treatment, it is segmented into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, hormone therapy, and others. Furthermore, the chemotherapy is segmented into antimetabolites, anthracyclines, taxanes, and alkylating agents. The targeted therapy is sub-segmented into tyrosine kinase inhibitors and monoclonal antibodies. And the hormone therapy is sub-segmented into estrogen-receptor modulators, aromatase inhibitors, and others. On the basis of the end user, it is segmented into hospitals & clinics, research institute, and others Get Complete Access of Report @ https://www.marketresearchfuture.com/reports/pancreatic-cancer-market-1638 . Related Reports Bone Pain Treatment Market Research Report- Global Forecast To 2027 Bone Cancer Market Research Report- Global Forecast To 2027 Medical Waste Management Equipment Market Research Report- Global Forecast To 2027 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Osteoarthritis Market – Overview: The rising geriatric and obese population are spurring the detection of osteoarthritis globally. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The market is anticipated to develop at a 6.8% CAGR in the forecast period. The increasing cases of osteoarthritis in the elderly population are the main demand drivers for the market. The market is expected to benefit from the augmented detection rates and improved accessibility to healthcare facilities where treatment can be sought. Increased investment in developing effective treatment options is anticipated to spur the osteoarthritis market’s growth in the forecast period. also read @ https://www.medgadget.com/2019/08/osteoarthritis-market-2019-size-trends-potential-growth-share-and-key-country-analysis-with-forecast-to-2023.html Segmental Analysis: The Osteoarthritis Market is segmented based on diagnosis, end users, type, and treatment. Based on type, the osteoarthritis market is segmented into wrist osteoarthritis, spinal osteoarthritis, hip osteoarthritis, and others. Based on diagnosis, the market is segmented into joint fluid analysis, imaging, and others. The imaging segment is additionally sub-segmented into X-rays, magnetic resonance imaging (MRI), and others. Based on treatment, the market is segmented into surgery, therapy, medication, and others. The medication segment is sub-segmented into analgesics, non-steroidal anti-inflammatory drugs and others. The analgesics sub-segment, on the basis of medication, is further segmented into acetaminophen, duloxetine, and others. The non-steroidal anti-inflammatory drugs sub-segment, on the basis of medication, is further segmented into naproxen sodium, ibuprofen, naproxen, aspirin, and others. Based on end users, the osteoarthritis market is segmented into hospitals & clinics, medical institutes, research organization, and others. Regional Analysis: The regional analysis of the osteoarthritis market observes that the American region controls the osteoarthritis market due to a strong healthcare sector and strong patient population for osteoarthritis. Apart from these factors, the varying lifestyles and growing healthcare spending have increased the development of the market in the American region. The European region is the next major osteoarthritis market, which is trailed by the Asia Pacific region. The accessibility to funds for research, vast patient population, growing healthcare expenses, well-developed healthcare sector and government backing for research & development are anticipated to boost the market development during the forecast period. Eastern Europe is the fastest mounting region due to the vast opportunities in the unexploited market. The Asia Pacific region is the fastest rising region in global market owing to the incidence of a vast patient population, constantly developing economies like India and China, and the existence of enormous opportunity in the market. Moreover, promising government policies and growing healthcare expenditures are fuelling the market development within the region. Conversely, the Middle East & African region controls the smallest portion in the osteoarthritis market globally owing to the incidence of a poor economy, particularly, in the African region. The Middle Eastern region holds a majority of the market of this region due to the strong healthcare sector and vast healthcare spending by countries like Saudi Arabia, Kuwait, Dubai, and Qatar. Browse More Information at: https://www.marketresearchfuture.com/reports/osteoarthritis-market-1609 Related Reports Bone Pain Treatment Market Research Report- Global Forecast To 2027 Bone Cancer Market Research Report- Global Forecast To 2027 Medical Waste Management Equipment Market Research Report- Global Forecast To 2027 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |